0173-0869 : Anoro Ellipta Respiratory (Inhalation) Powder


NDC: 0173-0869
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Anoro Ellipta
Dosage Form: Respiratory (Inhalation) Powder
Application #: NDA203975
Rev. Date: 


NDC Package Codes:

  • 0173-0869-06: 7 POWDER IN 1 INHALER (0173‑0869‑06)
  • 0173-0869-10: 30 POWDER IN 1 INHALER (0173‑0869‑10)
  • 0173-0869-61: 1 TRAY IN 1 CARTON (0173‑0869‑61) > 1 INHALER IN 1 TRAY > 7 POWDER IN 1 INHALER

Active Ingredients:

  • Umeclidinium Bromide
  • Vilanterol Trifenatate

Dosage Strength:

  • 62.5 ug/1
  • 25 ug/1

Pharmaceutical Classes:

  • Adrenergic beta2-Agonists [MoA]
  • Anticholinergic [EPC]
  • Cholinergic Antagonists [MoA]
  • beta2-Adrenergic Agonist [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0173-0869 QR Code

< Prev: 0173-0867Next: 0173-0873 >

Related Discussions:

Anoro Ellipta reactions
Has anyone had an itchy facial rash that got puffy and turned really red, and felt pretty hot? Anoro Ellipta is the only... 4 replies
Trelegy Ellipta drug interactions
Does anybody know what meds should not be taken with Trelegy Ellipta? I take Toprol-XL, Norvasc, Protonix, Xarelto, Proa... 2 replies
Side effects of breo ellipta
I was given a sample of breo ellipta for bronchitis.. just bronchitis. I was on it for 2 days when I ended up in the hos... 5 replies
Red spots from Incruse Ellipta and milk allergy?
I am taking Incruse Ellipta 62.5mcg inhaler (1 puff by mouth per day). It makes me have red blood spots on both arms. I ... 1 reply
Anoro gebruik
Bij inhalatie slaag ik er niet in alle medicatie te inhalleren, een deel van de korrels zitten achteraan mijn mond of ke...
vilanterol. Is anoro available in east africa.
is anoiro ellipta available in Africa. I want to know if anoro ellipta is being marketed in africa...
Trelegy Ellipta Inhaler Use
What is the longest you should hold Trelegy Ellipta in your lungs?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.